Chlorination Inhibitors in Streptomyces aureofaciens

IN a Belgian patent 1 granted to Spofa (Czechoslovakia) a number of pyrimidines chlorinated in the 2 position were reported to be active in inhibiting halogenation in the biosynthesis of chlortetracycline resulting instead in the production of high concentrations of tetracycline. It was of interest...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) 1968-07, Vol.219 (5151), p.291-292
Main Authors: GOODMAN, J. J, MATRISHIN, MARY
Format: Article
Language:English
Subjects:
Bromides - pharmacology
Chemistry, Pharmaceutical
Chlorine - metabolism
Chlortetracycline - biosynthesis
Depression, Chemical
Halogens
Humanities and Social Sciences
letter
multidisciplinary
Pyridazines - pharmacology
Pyrimidines - pharmacology
Science
Streptomyces - drug effects
Streptomyces - metabolism
Tetracycline - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IN a Belgian patent 1 granted to Spofa (Czechoslovakia) a number of pyrimidines chlorinated in the 2 position were reported to be active in inhibiting halogenation in the biosynthesis of chlortetracycline resulting instead in the production of high concentrations of tetracycline. It was of interest to us to test such compounds in the Streptomyces aureofaciens BC -41 system we have used before 2 . The two antibiotics were determined spectro-photometrically, taking advantage of their differential degradation rates in acid and alkaline solution. Compared with tetracycline, chlortetracycline is relatively stable to acid and unstable to base. Selected results were confirmed by paper chromatography. In the course of these trials, in which some thirty halogenated pyrimidines and related heterocycles were tested, very few were found to show activity. The most active compound was found to be 2,4-dichloro-5-methyl pyrimidine which, when added to the medium in a concentration of 10 p.p.m., resulted in the production of 80–95 per cent tetracycline in the final broth, confirming in part the work reported in the Belgian patent 1 . Closely related pyrimidines were either much less or not at all active for our strain BC -41. This is shown in Table 1.
ISSN:0028-0836
1476-4687
DOI:10.1038/219291a0